ArtsAutosBooksBusinessEducationEntertainmentFamilyFashionFoodGamesGenderHealthHolidaysHomeHubPagesPersonal FinancePetsPoliticsReligionSportsTechnologyTravel

New Cancer Drug Kymriah

Updated on October 4, 2017
Linda L Paquette profile image

Linda is a 56-year-old woman living all of her life in the North East. She has written a book of poetry "Heartfelt Emotions."

The New Wonder Drug

Science has come along way in the treatments of disease and seem to have opened the doors for a new drug Kymriah. This is the latest in fighting certain kinds of cancer. Many of the types of cancer Kymriah fights are found in children and young adults.

Kymriah was approved by the FDA back in August 2017. Every dose of Kymriah contains a patient's own immune cells, that are removed and then are sent to a lab to be genetically modified using a virus. The therapy , known as T-cell therapy, or CAR-T gives the cells the ability to recognize and kill the source of the cancer.

This is the first gene therapy drugs on the market right now, with more coming in the very near future.

How it Works

Kymriah uses a patient's own cells to attack the cancer. Dr. Stephen Grupp stated,"We've never seen anything like this before and I believe this therapy may become the new standard of care for the patient population". Dr. Grupp is the director of cancer immunotherapy at Children's Hospital in Philadelphia.

They extract a patient's own cells and send them to the lab to be modified and when given back to the patient the drug attacks the cancer cells.

Kymriah comes with side affects, as do all drugs but this one has a life threatening one of possible death from low pressure. The name for this is cytokine release syndrome or CRS. The drug to fight CRS is tocilizumab, which is also a new drug.

Hospitals must be certified to administer Kymriah to patient's. At the moment there are only 20 centers certified to administer Kymriah but they are expecting more than 30 by the end of 2017.

For more information:


Although the drug seems like a miracle the cost is phenomenal. Kymriah is a one time dose and its cost is over $400,000. which people are saying they thought it would be more expensive than that.

This price does not include hospitals generating the personal dose and the administration of the drug. The $475,000. is just for the drug itself.

Novartis, the company making the drug did make a deal that if a patient doesn't respond to the treatment within a month they will not make them pay.

A spokesman for CVS stated the company expects “CAR-T therapy will be covered under the medical benefit rather than the pharmacy benefit, which means that the medical health carrier and not the PBM will determine coverage for the drug.

All and all this seems to be a miracle drug and hopefully the science community continues and cancer in general one day will be a disease of the past..

You can read more here:

© 2017 Linda L Paquette


    0 of 8192 characters used
    Post Comment

    No comments yet.


    This website uses cookies

    As a user in the EEA, your approval is needed on a few things. To provide a better website experience, uses cookies (and other similar technologies) and may collect, process, and share personal data. Please choose which areas of our service you consent to our doing so.

    For more information on managing or withdrawing consents and how we handle data, visit our Privacy Policy at:

    Show Details
    HubPages Device IDThis is used to identify particular browsers or devices when the access the service, and is used for security reasons.
    LoginThis is necessary to sign in to the HubPages Service.
    Google RecaptchaThis is used to prevent bots and spam. (Privacy Policy)
    AkismetThis is used to detect comment spam. (Privacy Policy)
    HubPages Google AnalyticsThis is used to provide data on traffic to our website, all personally identifyable data is anonymized. (Privacy Policy)
    HubPages Traffic PixelThis is used to collect data on traffic to articles and other pages on our site. Unless you are signed in to a HubPages account, all personally identifiable information is anonymized.
    Amazon Web ServicesThis is a cloud services platform that we used to host our service. (Privacy Policy)
    CloudflareThis is a cloud CDN service that we use to efficiently deliver files required for our service to operate such as javascript, cascading style sheets, images, and videos. (Privacy Policy)
    Google Hosted LibrariesJavascript software libraries such as jQuery are loaded at endpoints on the or domains, for performance and efficiency reasons. (Privacy Policy)
    Google Custom SearchThis is feature allows you to search the site. (Privacy Policy)
    Google MapsSome articles have Google Maps embedded in them. (Privacy Policy)
    Google ChartsThis is used to display charts and graphs on articles and the author center. (Privacy Policy)
    Google AdSense Host APIThis service allows you to sign up for or associate a Google AdSense account with HubPages, so that you can earn money from ads on your articles. No data is shared unless you engage with this feature. (Privacy Policy)
    Google YouTubeSome articles have YouTube videos embedded in them. (Privacy Policy)
    VimeoSome articles have Vimeo videos embedded in them. (Privacy Policy)
    PaypalThis is used for a registered author who enrolls in the HubPages Earnings program and requests to be paid via PayPal. No data is shared with Paypal unless you engage with this feature. (Privacy Policy)
    Facebook LoginYou can use this to streamline signing up for, or signing in to your Hubpages account. No data is shared with Facebook unless you engage with this feature. (Privacy Policy)
    MavenThis supports the Maven widget and search functionality. (Privacy Policy)
    Google AdSenseThis is an ad network. (Privacy Policy)
    Google DoubleClickGoogle provides ad serving technology and runs an ad network. (Privacy Policy)
    Index ExchangeThis is an ad network. (Privacy Policy)
    SovrnThis is an ad network. (Privacy Policy)
    Facebook AdsThis is an ad network. (Privacy Policy)
    Amazon Unified Ad MarketplaceThis is an ad network. (Privacy Policy)
    AppNexusThis is an ad network. (Privacy Policy)
    OpenxThis is an ad network. (Privacy Policy)
    Rubicon ProjectThis is an ad network. (Privacy Policy)
    TripleLiftThis is an ad network. (Privacy Policy)
    Say MediaWe partner with Say Media to deliver ad campaigns on our sites. (Privacy Policy)
    Remarketing PixelsWe may use remarketing pixels from advertising networks such as Google AdWords, Bing Ads, and Facebook in order to advertise the HubPages Service to people that have visited our sites.
    Conversion Tracking PixelsWe may use conversion tracking pixels from advertising networks such as Google AdWords, Bing Ads, and Facebook in order to identify when an advertisement has successfully resulted in the desired action, such as signing up for the HubPages Service or publishing an article on the HubPages Service.
    Author Google AnalyticsThis is used to provide traffic data and reports to the authors of articles on the HubPages Service. (Privacy Policy)
    ComscoreComScore is a media measurement and analytics company providing marketing data and analytics to enterprises, media and advertising agencies, and publishers. Non-consent will result in ComScore only processing obfuscated personal data. (Privacy Policy)
    Amazon Tracking PixelSome articles display amazon products as part of the Amazon Affiliate program, this pixel provides traffic statistics for those products (Privacy Policy)